Promoting Development and Use of Care Models Sample Clauses

Promoting Development and Use of Care Models. If applicable to the QDP Issuer’s delivery system, please report the number of Covered California enrollees who have been assigned a primary care dentist. Number of Covered California enrollees who have been assigned a primary care dentist Number of Covered California enrollees
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Promoting Development and Use of Care Models. In addition to fostering appropriate linkage of enrollees with primary care providers, Contractor is encouraged to actively promote the development and use of care models that promote access, care coordination and early identification of at risk enrollees. Such models may include, but are not limited to: (a) Accountable Care Organizations (ACO); (b) Patient Centered Medical Homes (PCMH); (c) The use of a patient-centered, team-based approach to care delivery and member engagement;
Sample 1Sample 2
Promoting Development and Use of Care Models. In addition to fostering appropriate linkage of enrollees with primary care providers, Contractor is encouraged to actively promote the development and use of care models that promote access, care coordination and early identification of at risk enrollees. Such models may include, but are not limited to: (a) Accountable Care Organizations (ACO); (b) Patient Centered Medical Homes (PCMH); (c) The use of a patient-centered, team-based approach to care delivery and member engagement; (d) A focus on additional primary care recruitment, use of mid-level practitioners and development of new primary care and specialty clinics; (e) A focus on expanding primary care access through payment systems and strategies; (f) The use of an intensive outpatient care programs (“Ambulatory ICU”) for enrollees with complex chronic conditions; (g) The use of qualified health professionals to deliver coordinated patient education and health maintenance support, with a proven approach for improving care for high-risk and vulnerable populations; (h) Support of physician and patient engagement in shared decision-making; (i) Providing patient access to their health information; (j) Promoting team care; (k) The use of telemedicine; and (l) Promoting the use of remote patient monitoring. Contractor shall report annually, in a format to be mutually agreed upon between Contractor and Exchange, on: (1) the number and percentage of Plan Enrollees who have selected or been assigned to a Primary Care Provider, as described in Section 5.01;, (2) the enrollment of or usage by Plan Enrollees in the models described in Section 5.02 or such other models as the Contractor identifies as promoting better access, coordination and care for at risk enrollees; and (3) the results of such enrollment or services, including clinical, patient experience and costs impacts. In the event that the reporting requirements identified herein include Protected Health Information (PHI), Contractor shall provide the Exchange only with de-identified Protected Health Information as defined in 45 C.F.R. Section 164.514. All information provided to the Exchange in this section shall be treated by the Exchange as confidential information. Contractor shall not be required to provide the Exchange any data, information or reports that would violate peer review protections under applicable laws, rules and regulation.
Sample 1
Promoting Development and Use of Care Models. Contractor shall report annually, in a format to be mutually agreed upon between Contractor and Exchange, on: (1) the number and percentage of Plan Enrollees who have selected or been assigned to a Primary Care Provider, as described in Section 5.01. In the event that the reporting requirements identified herein include Protected Health Information, Contractor shall provide the Exchange only with
Sample 1
Promoting Development and Use of Care Models. In addition to fostering appropriate linkage of enrollees with primary care providers, Contractor is encouraged to actively promote the development and use of care models that promote access, care coordination and early identification of at risk enrollees. Such models may include, but are not limited to: (a) Accountable Care Organizations (ACO); (b) Patient Centered Medical Homes (PCMH); (c) The use of a patient-centered, team-based approach to care delivery and member engagement; (d) A focus on additional primary care recruitment, use of mid-level practitioners and development of new primary care and specialty clinics; (e) A focus on expanding primary care access through payment systems and strategies; (f) The use of an intensive outpatient care programs (“Ambulatory ICU”) for enrollees with complex chronic conditions; (g) The use of qualified health professionals to deliver coordinated patient education and health maintenance support, with a proven approach for improving care for high-risk and vulnerable populations; (h) Support of physician and patient engagement in shared decision-making; (i) Providing patient access to their health information; (j) Promoting team care; (k) The use of telemedicine; and (l) Promoting the use of remote patient monitoring.
Sample 1

Related to Promoting Development and Use of Care Models

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

  • Additional Products and Services Subject to the allocation of funds, the CPO may add similar equipment, supplies, services, or locations, within the scope of this Agreement, to the list of equipment, supplies, services, or locations to be performed or provided by giving written notification to Contractor. For purposes of this Section, the “Effective Date” means the date specified in the notification from the CPO. As of the Effective Date, each item added is subject to this Agreement, as if it had originally been a part, but the charge for each item starts to accrue only on the Effective Date. In the event the additional equipment, supplies, services, or locations are not identical to the items(s) already under this Agreement, the charges therefor will then be Contractor’s normal and customary charges or rates for the equipment, supplies, services, or locations classified in the Fees and Costs (Exhibit “F”).

  • Diagnostic Services Procedures ordered by a recognized Provider because of specific symptoms to diagnose a specific condition or disease. Some examples include, but are not limited to:

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!